Moreno-Vargas L, Prada-Gracia D
Int J Mol Sci. 2025; 26(1.
PMID: 39795918
PMC: 11720145.
DOI: 10.3390/ijms26010059.
Alboreggia G, Udompholkul P, Baggio C, Muzzarelli K, Assar Z, Pellecchia M
J Med Chem. 2024; 67(10):8172-8185.
PMID: 38695666
PMC: 11129181.
DOI: 10.1021/acs.jmedchem.4c00277.
Li F, Liu J, Liu C, Liu Z, Peng X, Huang Y
Nat Commun. 2024; 15(1):1476.
PMID: 38368459
PMC: 10874388.
DOI: 10.1038/s41467-024-45848-1.
Hawley K, Eclov R, Schnorenberg M, Tian Y, Shah R, Thomas-Toth A
Proc Natl Acad Sci U S A. 2022; 119(42):e2209044119.
PMID: 36227917
PMC: 9586281.
DOI: 10.1073/pnas.2209044119.
Tian Y, Tirrell M, LaBelle J
Adv Healthc Mater. 2022; 11(12):e2102600.
PMID: 35285167
PMC: 9232950.
DOI: 10.1002/adhm.202102600.
Biosynthetic Strategies for Macrocyclic Peptides.
Wang W, Khojasteh S, Su D
Molecules. 2021; 26(11).
PMID: 34206124
PMC: 8199541.
DOI: 10.3390/molecules26113338.
Peptide-based inhibitors of protein-protein interactions: biophysical, structural and cellular consequences of introducing a constraint.
Wang H, Dawber R, Zhang P, Walko M, Wilson A, Wang X
Chem Sci. 2021; 12(17):5977-5993.
PMID: 33995995
PMC: 8098664.
DOI: 10.1039/d1sc00165e.
Design, Synthesis, and Structural Characterization of Lysine Covalent BH3 Peptides Targeting Mcl-1.
Gambini L, Udompholkul P, Baggio C, Muralidharan A, Kenjic N, Assar Z
J Med Chem. 2021; 64(8):4903-4912.
PMID: 33797903
PMC: 8550878.
DOI: 10.1021/acs.jmedchem.1c00005.
Preferential targeting of MCL-1 by a hydrocarbon-stapled BIM BH3 peptide.
Hadji A, Schmitt G, Schnorenberg M, Roach L, Hickey C, Leak L
Oncotarget. 2019; 10(58):6219-6233.
PMID: 31692812
PMC: 6817437.
DOI: 10.18632/oncotarget.27262.
Activating the Intrinsic Pathway of Apoptosis Using BIM BH3 Peptides Delivered by Peptide Amphiphiles with Endosomal Release.
Schnorenberg M, Bellairs J, Samaeekia R, Acar H, Tirrell M, LaBelle J
Materials (Basel). 2019; 12(16).
PMID: 31408950
PMC: 6719084.
DOI: 10.3390/ma12162567.
Flow Cytometry-Based Detection and Analysis of BCL-2 Family Proteins and Mitochondrial Outer Membrane Permeabilization (MOMP).
Ludwig L, Maxcy K, LaBelle J
Methods Mol Biol. 2018; 1877:77-91.
PMID: 30535999
PMC: 6704474.
DOI: 10.1007/978-1-4939-8861-7_5.
Cell Penetration Profiling Using the Chloroalkane Penetration Assay.
Peraro L, Deprey K, Moser M, Zou Z, Ball H, Levine B
J Am Chem Soc. 2018; 140(36):11360-11369.
PMID: 30118219
PMC: 6205923.
DOI: 10.1021/jacs.8b06144.
Emerging Methods and Design Principles for Cell-Penetrant Peptides.
Peraro L, Kritzer J
Angew Chem Int Ed Engl. 2018; 57(37):11868-11881.
PMID: 29740917
PMC: 7184558.
DOI: 10.1002/anie.201801361.
IKKγ-Mimetic Peptides Block the Resistance to Apoptosis Associated with Kaposi's Sarcoma-Associated Herpesvirus Infection.
Briggs L, Chan A, Davis C, Whitelock N, Hotiana H, Baratchian M
J Virol. 2017; 91(23).
PMID: 28931678
PMC: 5686756.
DOI: 10.1128/JVI.01170-17.
Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents.
Cho C, Wolfe J, Fadzen C, Calligaris D, Hornburg K, Chiocca E
Nat Commun. 2017; 8:15623.
PMID: 28585535
PMC: 5467173.
DOI: 10.1038/ncomms15623.
A critical assessment of the synthesis and biological activity of p53/human double minute 2-stapled peptide inhibitors.
Wallbrecher R, Chene P, Ruetz S, Stachyra T, Vorherr T, Brock R
Br J Pharmacol. 2017; 174(16):2613-2622.
PMID: 28436014
PMC: 5522989.
DOI: 10.1111/bph.13834.
Electrophilic Helical Peptides That Bond Covalently, Irreversibly, and Selectively in a Protein-Protein Interaction Site.
de Araujo A, Lim J, Good A, Skerlj R, Fairlie D
ACS Med Chem Lett. 2017; 8(1):22-26.
PMID: 28105269
PMC: 5238470.
DOI: 10.1021/acsmedchemlett.6b00395.
Mechanistic validation of a clinical lead stapled peptide that reactivates p53 by dual HDM2 and HDMX targeting.
Wachter F, Morgan A, Godes M, Mourtada R, Bird G, Walensky L
Oncogene. 2016; 36(15):2184-2190.
PMID: 27721413
PMC: 5386833.
DOI: 10.1038/onc.2016.361.
Selective Covalent Targeting of Anti-Apoptotic BFL-1 by Cysteine-Reactive Stapled Peptide Inhibitors.
Huhn A, Guerra R, Harvey E, Bird G, Walensky L
Cell Chem Biol. 2016; 23(9):1123-1134.
PMID: 27617850
PMC: 5055752.
DOI: 10.1016/j.chembiol.2016.07.022.
Development of a lytic peptide derived from BH3-only proteins.
Liu Q, Zhao H, Jiang Y, Wu M, Tian Y, Wang D
Cell Death Discov. 2016; 2:16008.
PMID: 27551502
PMC: 4979451.
DOI: 10.1038/cddiscovery.2016.8.